OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
December 03, 2009
Novartis officially inaugurated its large-scale flu cell-culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina.
December 02, 2009
Particularly in a more connected world, individual contributions can make a difference.
Leading experts share insight on polymorphism and crystallization.
Polymorph screening is a critical step in developing an active pharmaceutical ingredient for a pharmaceutical formulation.
Gerry Migliaccio, senior vice-president of network performance for Pfizer Global Manufacturing, offers perspectives on building supply-chain integrity in emerging markets.
The custom manufacturer and fine-chemicals company adds further capabilities in high-potency and viral-product manufacturing and targets synergies in gene editing with its parent company, Sigma-Aldrich.